| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
101,734,000 |
| Market
Cap: |
36.23(M) |
| Last
Volume: |
356,534 |
Avg
Vol: |
349,200 |
| 52
Week Range: |
$0.1577 - $0.399456 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile BioLargo is a technology developer and environmental engineering company. Odor-No-More, Inc., Co.'s subsidiary, manufactures and sells its odor and volatile organic compound control products. Its subsidiary, BioLargo Engineering, Science & Technologies, LLC, is an engineering services division supporting its internal business units and serving outside clients on a fee for service basis. BioLargo Water, Inc., Co.'s Canadian subsidiary, focuses on commercializing its Advanced Oxidation System, which is a water treatment device. Clyra Medical Technologies, Inc., its partially owned subsidiary, is focused on the Advanced Wound Care industry.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Code Kenneth Reay |
Chief Science Officer |
• • – |
2023-12-31 |
4 |
A |
$0.17 |
$12,200 |
D/D |
72,621 |
25,062,579 |
|
- |
|
| Calvert Dennis P |
President |
• • – |
2023-12-31 |
4 |
A |
$0.17 |
$8,494 |
D/D |
50,557 |
9,860,044 |
|
- |
|
| Code Kenneth Reay |
Chief Science Officer |
• • – |
2023-09-30 |
4 |
A |
$0.17 |
$3,150 |
D/D |
19,010 |
24,989,958 |
|
- |
|
| Calvert Dennis P |
President |
• • – |
2023-07-24 |
4 |
A |
$0.18 |
$9,049 |
D/D |
50,553 |
9,809,487 |
|
- |
|
| Code Kenneth Reay |
Chief Science Officer |
• • – |
2023-06-30 |
4 |
A |
$0.18 |
$12,200 |
D/D |
68,541 |
24,970,948 |
|
- |
|
| Park Linda |
Director |
– • – |
2022-11-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,862 |
|
-19% |
|
| Park Linda |
Director |
– • – |
2022-11-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
187,500 |
|
-19% |
|
| Calvert Dennis P |
President |
• • – |
2022-10-03 |
4 |
A |
$0.27 |
$27,148 |
D/D |
100,549 |
9,758,934 |
|
- |
|
| Code Kenneth Reay |
Chief Science Officer |
• • – |
2022-10-03 |
4 |
A |
$0.27 |
$45,301 |
D/D |
167,781 |
24,871,660 |
|
- |
|
| Calvert Dennis P |
President |
• • – |
2022-07-07 |
4 |
A |
$0.18 |
$28,100 |
D/D |
156,111 |
9,658,385 |
|
- |
|
| Code Kenneth Reay |
Chief Science Officer |
• • – |
2022-06-30 |
4 |
A |
$0.18 |
$19,401 |
D/D |
107,784 |
24,703,879 |
|
- |
|
| Code Kenneth Reay |
Chief Science Officer |
• • – |
2021-12-31 |
4 |
A |
$0.21 |
$3,150 |
D/D |
15,000 |
24,596,095 |
|
- |
|
| Calvert Dennis P |
President |
• • – |
2021-12-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
156,000 |
9,502,274 |
|
- |
|
| Code Kenneth Reay |
Chief Science Officer |
• • • |
2021-10-05 |
4 |
A |
$0.19 |
$11,750 |
D/D |
61,842 |
24,581,095 |
|
- |
|
| Strommen Jack B. |
Director |
• • – |
2021-04-20 |
4 |
OE |
$0.24 |
$135,128 |
D/D |
563,035 |
4,878,579 |
|
- |
|
| Calvert Dennis P |
President |
• • – |
2020-12-31 |
4 |
A |
$0.12 |
$37,951 |
D/D |
316,260 |
9,596,516 |
|
- |
|
| Calvert Dennis P |
President |
• • – |
2020-12-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
225,000 |
9,280,256 |
|
- |
|
| Calvert Dennis P |
President |
• • – |
2020-10-06 |
4 |
A |
$0.15 |
$24,650 |
D/D |
164,331 |
9,505,256 |
|
- |
|
| Calvert Dennis P |
President |
• • – |
2020-09-30 |
4 |
A |
$0.15 |
$24,650 |
D/D |
164,331 |
9,505,256 |
|
- |
|
| Code Kenneth Reay |
Chief Science Officer |
• • • |
2020-09-30 |
4 |
A |
$0.15 |
$27,801 |
D/D |
185,339 |
24,107,807 |
|
- |
|
| Calvert Dennis P |
President |
• • – |
2020-06-30 |
4 |
A |
$0.16 |
$32,149 |
D/D |
200,929 |
9,340,925 |
|
- |
|
| Code Kenneth Reay |
Chief Science Officer |
• • • |
2020-06-30 |
4 |
A |
$0.16 |
$26,636 |
D/D |
166,474 |
23,922,468 |
|
- |
|
| Calvert Dennis P |
President |
• • – |
2020-03-31 |
4 |
A |
$0.17 |
$47,900 |
D/D |
281,762 |
9,139,996 |
|
- |
|
| Code Kenneth Reay |
Chief Science Officer |
• • • |
2020-03-31 |
4 |
A |
$0.17 |
$62,389 |
D/D |
366,993 |
23,755,994 |
|
- |
|
| Calvert Dennis P |
President |
• • – |
2020-03-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
8,858,234 |
|
- |
|
79 Records found
|
|
Page 1 of 4 |
|
|
